Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Depression Screening and Patient Outcomes in Cardiovascular Care
2008
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
2011
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
2006
Venous Thromboembolism and Cancer: Prevention of VTE
2001
Proficient and Cost-Effective Approaches for the Prevention and Treatment of Venous Thrombosis and Thromboembolism
2000
Incidence of Hematoma Complication with Heparin Venous Thrombosis Prophylaxis after TRAM Flap Breast Reconstruction
2008
Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients
2007
Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials
1997
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Burden of liver diseases in the world
2018 Standout
Oxidative stress and calcium signaling in the adverse effects of environmental particles (PM10)
2003
Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis
1997
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
Effects of a Low-Molecular-Weight Heparin on Thrombus Regression and Recurrent Thromboembolism in Patients with Deep-Vein Thrombosis
2001
Clinical Recognition of Pulmonary Embolism: Problem of Unrecognized and Asymptomatic Cases
1998
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
1996
Deep-vein thrombosis
1999
The Effect of Low Molecular Weight Heparin Thromboprophylaxis on Bleeding Complications After Gastric Cancer Surgery
2010
Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy
2003
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Effects of stress on the development and progression of cardiovascular disease
2017
Thermally Injured Patients Are at Significant Risk for Thromboembolic Complications
2001
Fatal pulmonary embolism in hospitalised patients: a necropsy review
2004
Retinitis pigmentosa
2006 Standout
Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke
1995
Diabetes and Atherosclerosis
2002 Standout
Low Molecular Weight Heparin and Unfractionated Heparin in Thrombosis Prophylaxis: Meta-Analysis Based on Original Patient Data
2001
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Clinical relevance of the fibrinogen uptake test in patients undergoing elective general abdominal surgery—relation to major thromboembolism and mortality
1995
Atmospheric Aerosols: Composition, Transformation, Climate and Health Effects
2005 Standout
Venous thromboembolism (VTE) in Europe
2007 Standout
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
2002 Standout
Prevention of Venous Thromboembolism
2004 Standout
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice
2004
Stress and cardiovascular disease
2012
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Pursuing prosthetic electronic skin
2016 Standout
A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery
1995
Prevention of Venous Thromboembolism
2008 Standout
Cost Effectiveness of Dalteparin for Preventing Venous Thromboembolism in Abdominal Surgery
2005
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study
2003
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Retinal Ganglion Cells Survive and Maintain Normal Dendritic Morphology in a Mouse Model of Inherited Photoreceptor Degeneration
2008
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial
2002 Standout
Carbon monoxide in biology and medicine
2004
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
2000 Standout
A 20-year retrospective review of global aquaculture
2021 StandoutNature
Heme oxygenase-1 and carbon monoxide in pulmonary medicine
2003
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Thromboembolic Risk Assessment and the Efficacy of Enoxaparin Prophylaxis in Excisional Body Contouring Surgery
2008
Prevention of Venous Thromboembolism
1998
Enoxaparin Increases the Incidence of Postoperative Intracranial Hemorrhage when Initiated Preoperatively for Deep Venous Thrombosis Prophylaxis in Patients with Brain Tumors
1998
Management of Anticoagulation before and after Elective Surgery
1997
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
1 Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology
1997
Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
2003
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Antiplatelet treatment for thromboprophylaxis: a step forward or backwards?
1994
Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery
2004
Post Discharge Clinically Overt Venous Thromboembolism in Orthopaedic Surgery Patients with Negative Venography -an Overview Analysis
1996
Use of chemicals and biological products in Asian aquaculture and their potential environmental risks: a critical review
2012
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
2006 Standout
State-of the-Art Review : Prevention of Thrombosis in Gynecologic Malignancy
1998
Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials
2012
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
2000
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Disease Tolerance as a Defense Strategy
2012 StandoutScience
Reversible Photocontrol of Biological Systems by the Incorporation of Molecular Photoswitches
2013 StandoutNobel
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Pathogenesis and Prophylaxis of Postoperative Thromboembolic Disease in Urological Pelvic Surgery
1995
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Polymers for neural implants
2010
Low-Molecular-Weight Heparins
1997 Standout
Thromboembolic Prophylaxis in Moderate‐Risk Patients Undergoing Elective Abdominal Surgery: Decision and Cost‐Effectiveness Analyses
1996
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
1997 Standout
Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analyses
1997
Comparison of Unfractionated Versus Low Molecular Weight Heparin for Deep Vein Thrombosis Prophylaxis During Breast and Pelvic Cancer Surgery: Efficacy, Safety, and Follow-up
1998
Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patients
1995
Prevention of Venous Thromboembolism
1995
Graduated compression stockings in the prevention of venous thromboembolism
1999
Piccolo and bassoon maintain synaptic vesicle clustering without directly participating in vesicle exocytosis
2010 StandoutNobel
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients
2005
Early Synaptic Defects intulp1−/−Mice
2009
Comparison of the Mechanism of Toxicity of Zinc Oxide and Cerium Oxide Nanoparticles Based on Dissolution and Oxidative Stress Properties
2008 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Prevention and Treatment of Thrombo-embolic Disease in Gynaecological Surgery
1999
Low‐Molecular‐Weight Heparin versus Warfarin for Prevention of Recurrent Venous Thromboembolism: A Randomized Trial
1996
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice
2004
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
2001
Works of M. Phillips being referenced
“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999
2001
The use of chemicals in carp and shrimp aquaculture in Bangladesh, Cambodia, Lao PDR, Nepal, Pakistan, Sri Lanka and Viet Nam.
2000
Two mouse retinal degenerations caused by missense mutations in the β-subunit of rod cGMP phosphodiesterase gene
2007
Status of the feline retina 5 years after subretinal implantation
2006
The Changing Pattern of Venous Thromboembolic Disease
1996
Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery
1993
Possible sources of neuroprotection following subretinal silicon chip implantation in RCS rats
2005
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data
2010
A Dose Ranging Study to Evaluate Dermatan Sulphate in Preventing Deep Vein Thrombosis following Total Hip Arthroplasty
1994
Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK /French study
2015
Psychological treatment of cardiac patients: a meta-analysis
2007